Cephalon Provigil Pediatric ADHD Filing Slated For Fourth Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is accelerating the filing timeline for modafinil in attention deficit hyperactivity disorder based on positive Phase III data in children and adolescents. Cephalon will seek a different brand name for the indication.